Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients.
Hackert, Thilo
Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients. [electronic resource] - Annals of surgery 09 2016 - 457-63 p. digital
Publication Type: Journal Article
1528-1140
10.1097/SLA.0000000000001850 doi
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Deoxycytidine--administration & dosage
Female
Humans
Male
Middle Aged
Neoadjuvant Therapy--methods
Pancreatic Neoplasms--drug therapy
Gemcitabine
Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients. [electronic resource] - Annals of surgery 09 2016 - 457-63 p. digital
Publication Type: Journal Article
1528-1140
10.1097/SLA.0000000000001850 doi
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Deoxycytidine--administration & dosage
Female
Humans
Male
Middle Aged
Neoadjuvant Therapy--methods
Pancreatic Neoplasms--drug therapy
Gemcitabine